Efficacy and adverse effects of clozapine in the treatment of schizophrenia and tardive dyskinesia — a retrospective study of 387 patients
✍ Scribed by D. Naber; M. Leppig; R. Grohmann; H. Hippius
- Publisher
- Springer
- Year
- 1989
- Tongue
- English
- Weight
- 491 KB
- Volume
- 99
- Category
- Article
- ISSN
- 0033-3158
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Six patients with severe and stable tardive dyskinesia were treated with verapamil, a calcium channel blocker, in doses ranging from 240 to 400 mg/day. Weekly assessments were made using the Simpson tardive dyskinesia rating scale. Neuroleptic medication was held constant during the 3-month baseline
## Abstract Objective: Treatment resistance in early onset schizophrenia (EOS) is one of the most challenging problems in child and adolescent psychiatry. We retrospectively examined the therapeutic dosage, clinical response, and side effect profiles of long‐term clozapine treatment in Korean child
## Abstract ## Background Fractionated carbon dioxide CO~2~ laser resurfacing unites the idea of fractional photothermolysis with an ablative 10,600‐nm wavelength. This technology permits effective treatment of deeper rhytides, photodamaged skin, and scars, with shorter recovery and a decreased si